Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Madrigal Pharmaceuticals
MDGL
$12.4B
| $46.3M | 0.01% |
153,085
+1,834
| +1% | +$546K |
|
1152
Avantor
AVTR
$9.33B
| $46.3M | 0.01% |
3,438,719
+146,505
| +4% | +$2M |
|
|
CNR
1153
Core Natural Resources Inc
CNR
$4.64B
| $46.3M | 0.01% |
663,608
+32,864
| +5% | +$2.34M |
|
1154
Semtech
SMTC
$13.1B
| $46.1M | 0.01% |
1,021,134
+24,711
| +2% | +$879K |
|
1155
Vaxcyte
PCVX
$8.88B
| $46.1M | 0.01% |
1,417,711
+84,329
| +6% | +$2.76M |
|
1156
Four Corners Property Trust
FCPT
$2.72B
| $45.9M | 0.01% |
1,705,806
+43,891
| +3% | +$1.21M |
|
1157
Pricesmart
PSMT
$5.51B
| $45.8M | 0.01% |
436,162
-20,753
| -5% | -$2.09M |
|
1158
Mueller Water Products
MWA
$4.07B
| $45.8M | 0.01% |
1,904,580
-11,862
| -0.6% | -$293K |
|
1159
Archer Aviation
ACHR
$4.88B
| $45.8M | 0.01% |
4,219,040
+1,113,617
| +36% | +$10.4M |
|
1160
PennyMac Financial
PFSI
$3.97B
| $45.7M | 0.01% |
458,238
+1,004
| +0.2% | +$97.3K |
|
1161
ADMA Biologics
ADMA
$2.21B
| $45.6M | 0.01% |
2,502,026
+40,021
| +2% | +$816K |
|
1162
Verra Mobility
VRRM
$717M
| $45.4M | 0.01% |
1,789,894
+23,185
| +1% | +$540K |
|
1163
Kontoor Brands
KTB
$4.46B
| $45.4M | 0.01% |
688,634
+12,015
| +2% | +$777K |
|
1164
CRISPR Therapeutics
CRSP
$5.2B
| $45.4M | 0.01% |
933,204
+219,665
| +31% | +$8.5M |
|
1165
Amkor Technology
AMKR
$14.1B
| $45.2M | 0.01% |
2,153,491
+61,413
| +3% | +$1.13M |
|
1166
Credit Acceptance
CACC
$5.94B
| $45.2M | 0.01% |
88,653
-4,459
| -5% | -$2.19M |
|
1167
Starwood Property Trust
STWD
$6.12B
| $45.1M | 0.01% |
2,247,590
+52,648
| +2% | +$1.02M |
|
1168
Cavco Industries
CVCO
$4.61B
| $45M | 0.01% |
103,483
-5,884
| -5% | -$2.76M |
|
1169
Cytokinetics
CYTK
$10.6B
| $44.8M | 0.01% |
1,357,117
+44,260
| +3% | +$1.54M |
|
1170
Weatherford International
WFRD
$6.69B
| $44.8M | 0.01% |
889,653
+81,525
| +10% | +$3.79M |
|
1171
Upstart Holdings
UPST
$2.83B
| $44.6M | 0.01% |
690,122
+32,267
| +5% | +$1.58M |
|
1172
Fortune Brands Innovations
FBIN
$5.81B
| $44.6M | 0.01% |
865,724
-2,321
| -0.3% | -$121K |
|
1173
Kemper
KMPR
$1.57B
| $44.3M | 0.01% |
686,252
-45,181
| -6% | -$2.8M |
|
1174
Carter's
CRI
$1.44B
| $44.3M | 0.01% |
1,469,629
+142,589
| +11% | +$4.83M |
|
1175
Urban Edge Properties
UE
$2.74B
| $44.2M | 0.01% |
2,368,820
+36,913
| +2% | +$675K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.